Nonpeptidal P-2 ligands for HIV protease inhibitors: Structure-based design, synthesis, and biological evaluation

被引:81
作者
Ghosh, AK
Kincaid, JF
Walters, DE
Chen, Y
Chaudhuri, NC
Thompson, WJ
Culberson, C
Fitzgerald, PMD
Lee, HY
McKee, SP
Munson, PM
Duong, TT
Darke, PL
Zugay, JA
Schleif, WA
Axel, MG
Lin, J
Huff, JR
机构
[1] FINCH UNIV HLTH SCI CHICAGO MED SCH, DEPT BIOL CHEM, N CHICAGO, IL 60616 USA
[2] MERCK RES LABS, W POINT, PA 19486 USA
[3] MERCK RES LABS, RAHWAY, NJ 07065 USA
关键词
D O I
10.1021/jm960128k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Design and synthesis of nonpeptidal bis-tetrahydrofuran ligands based upon the X-ray crystal structure of the HIV-1 protease-inhibitor complex 1 led to replacement of two amide bonds and a 10 pi-aromatic system of Ro 31-8959 class of HIV protease inhibitors. Detailed structure-activity studies have now established that the position of ring oxygens, ring size, and stereochemistry are all crucial to potency. Of particular interest, compound 49 with (3S,3aS,6aS)-bis-Thf is the most potent inhibitor (IC50 value 1.8 +/- 0.2 nM; CIC95 value 46 +/- 4 nM) in this series. The X-ray structure of protein-inhibitor complex 49 has provided insight into the ligand-binding site interactions. As it turned out, both oxygens in the bis-Thf ligands are involved in hydrogen-bonding interactions with Asp 29 and Asp 30 NH present in the S-2 subsite of HIV-1 protease. Stereoselective routes have been developed to obtain these novel ligands in optically pure form.
引用
收藏
页码:3278 / 3290
页数:13
相关论文
共 46 条
  • [1] NEW AND SELECTIVE REACTIONS AND REAGENTS IN CARBOHYDRATE-CHEMISTRY
    BARTON, DHR
    MOTHERWELL, WB
    [J]. PURE AND APPLIED CHEMISTRY, 1981, 53 (01) : 15 - 31
  • [2] ANHYDRIDES AS ACYLATING AGENTS IN LIPASE-CATALYZED STEREOSELECTIVE ESTERIFICATION OF RACEMIC ALCOHOLS
    BIANCHI, D
    CESTI, P
    BATTISTEL, E
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (23) : 5531 - 5534
  • [3] Clare Michael, 1993, Perspectives in Drug Discovery and Design, V1, P49, DOI 10.1007/BF02171655
  • [4] ANTIVIRAL PROPERTIES OF RO 31-8959, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PROTEINASE
    CRAIG, JC
    DUNCAN, IB
    HOCKLEY, D
    GRIEF, C
    ROBERTS, NA
    MILLS, JS
    [J]. ANTIVIRAL RESEARCH, 1991, 16 (04) : 295 - 305
  • [5] ALPHA-METHOXY-ALPHA-TRIFLUOROMETHYLPHENYLACETIC ACID, A VERSATILE REAGENT FOR DETERMINATION OF ENANTIOMERIC COMPOSITION OF ALCOHOLS AND AMINES
    DALE, JA
    DULL, DL
    MOSHER, HS
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1969, 34 (09) : 2543 - &
  • [6] Darke P L, 1994, Adv Pharmacol, V25, P399, DOI 10.1016/S1054-3589(08)60438-X
  • [7] THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS
    DEBOUCK, C
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) : 153 - 164
  • [8] DELFRAISSY JF, 1993, PHASE 1 2 DOSE RANGI
  • [9] L-735,524 - THE DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR
    DORSEY, BD
    LEVIN, RB
    MCDANIEL, SL
    VACCA, JP
    GUARE, JP
    DARKE, PL
    ZUGAY, JA
    EMINI, EA
    SCHLEIF, WA
    QUINTERO, JC
    LIN, JH
    CHEN, IW
    HOLLOWAY, MK
    FITZGERALD, PMD
    AXEL, MG
    OSTOVIC, D
    ANDERSON, PS
    HUFF, JR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (21) : 3443 - 3451
  • [10] PREPARATION OF 4-ACYL-3-METHYLENETETRAHYDROFURANS - OBTAINMENT OF ALPHA-METHYLENE-GAMMA-LACTONES AND FUNCTIONALIZED BUTENOLIDES
    DULCERE, JP
    RODRIGUEZ, J
    SANTELLI, M
    ZAHRA, JP
    [J]. TETRAHEDRON LETTERS, 1987, 28 (18) : 2009 - 2012